BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

被引：23

作者：

Lebbe, Celeste ^{[1
,2
,3
]}

How-Kit, Alexandre ^{[4
]}

Battistella, Maxime ^{[2
,5
]}

Sadoux, Aurelie ^{[6
]}

Podgorniak, Marie-Pierre ^{[6
]}

Sidina, Irina ^{[1
]}

Pages, Cecile ^{[1
]}

Roux, Jennifer ^{[1
]}

Porcher, Raphael ^{[2
,7
]}

Tost, Jorg ^{[8
]}

Mourah, Samia ^{[2
,7
,9
]}

机构：

[1] Hop St Louis, AP HP, Dept Dermatol, F-75010 Paris, France

[2] Paris Diderot Univ, Sorbonne Paris Cite, Paris, France

[3] INSERM, U976, Paris, France

[4] Jean Dausset Fdn CEPH, Lab Funct Genom, Paris, France

[5] Hop St Louis, AP HP, Pathol Lab, INSERM,UMR S 1165, F-75010 Paris, France

[6] Hop St Louis, AP HP, Pharmacol Genet Lab, F-75010 Paris, France

[7] INSERM, U717, Dept Biostat & Med Data Proc, Paris, France

[8] CEA, Lab Epigenet & Environm, Genotyping Natl Ctr, Genom Inst, Paris, France

[9] INSERM, UMR S 940, Paris, France

来源：

MELANOMA RESEARCH | 2014年 / 24卷 / 04期

关键词：

BRAF; DABRAFENIB; INHIBITORS; SURVIVAL;

D O I：

10.1097/CMR.0000000000000088

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：415 / 418

页数：4

共 12 条

[1] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].

Chapman, Paul B. ;

Hauschild, Axel ;

Robert, Caroline ;

Haanen, John B. ;

Ascierto, Paolo ;

Larkin, James ;

Dummer, Reinhard ;

Garbe, Claus ;

Testori, Alessandro ;

Maio, Michele ;

Hogg, David ;

Lorigan, Paul ;

Lebbe, Celeste ;

Jouary, Thomas ;

Schadendorf, Dirk ;

Ribas, Antoni ;

O'Day, Steven J. ;

Sosman, Jeffrey A. ;

Kirkwood, John M. ;

Eggermont, Alexander M. M. ;

Dreno, Brigitte ;

Nolop, Keith ;

Li, Jiang ;

Nelson, Betty ;

Hou, Jeannie ;

Lee, Richard J. ;

Flaherty, Keith T. ;

McArthur, Grant A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516

[2] Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial [J].

Falchook, Gerald S. ;

Long, Georgina V. ;

Kurzrock, Razelle ;

Kim, Kevin B. ;

Arkenau, Tobias H. ;

Brown, Michael P. ;

Hamid, Omid ;

Infante, Jeffrey R. ;

Millward, Michael ;

Pavlick, Anna C. ;

O'Day, Steven J. ;

Blackman, Samuel C. ;

Curtis, C. Martin ;

Lebowitz, Peter ;

Ma, Bo ;

Ouellet, Daniele ;

Kefford, Richard F. .

LANCET, 2012, 379 (9829) :1893-1901

[3] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].

Flaherty, Keith T. ;

Puzanov, Igor ;

Kim, Kevin B. ;

Ribas, Antoni ;

McArthur, Grant A. ;

Sosman, Jeffrey A. ;

O'Dwyer, Peter J. ;

Lee, Richard J. ;

Grippo, Joseph F. ;

Nolop, Keith ;

Chapman, Paul B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819

[4] Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial [J].

Hauschild, Axel ;

Grob, Jean-Jacques ;

Demidov, Lev V. ;

Jouary, Thomas ;

Gutzmer, Ralf ;

Millward, Michael ;

Rutkowski, Piotr ;

Blank, Christian U. ;

Miller, Wilson H., Jr. ;

Kaempgen, Eckhart ;

Martin-Algarra, Salvador ;

Karaszewska, Boguslawa ;

Mauch, Cornelia ;

Chiarion-Sileni, Vanna ;

Martin, Anne-Marie ;

Swann, Suzanne ;

Haney, Patricia ;

Mirakhur, Beloo ;

Guckert, Mary E. ;

Goodman, Vicki ;

Chapman, Paul B. .

LANCET, 2012, 380 (9839) :358-365

[5] RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF [J].

Poulikakos, Poulikos I. ;

Zhang, Chao ;

Bollag, Gideon ;

Shokat, Kevan M. ;

Rosen, Neal .

NATURE, 2010, 464 (7287) :427-U126

[6] Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance [J].

Shi, Hubing ;

Moriceau, Gatien ;

Kong, Xiangju ;

Lee, Mi-Kyung ;

Lee, Hane ;

Koya, Richard C. ;

Ng, Charles ;

Chodon, Thinle ;

Scolyer, Richard A. ;

Dahlman, Kimberly B. ;

Sosman, Jeffrey A. ;

Kefford, Richard F. ;

Long, Georgina V. ;

Nelson, Stanley F. ;

Ribas, Antoni ;

Lo, Roger S. .

NATURE COMMUNICATIONS, 2012, 3

[7] Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib [J].

Sosman, Jeffrey A. ;

Kim, Kevin B. ;

Schuchter, Lynn ;

Gonzalez, Rene ;

Pavlick, Anna C. ;

Weber, Jeffrey S. ;

McArthur, Grant A. ;

Hutson, Thomas E. ;

Moschos, Stergios J. ;

Flaherty, Keith T. ;

Hersey, Peter ;

Kefford, Richard ;

Lawrence, Donald ;

Puzanov, Igor ;

Lewis, Karl D. ;

Amaravadi, Ravi K. ;

Chmielowski, Bartosz ;

Lawrence, H. Jeffrey ;

Shyr, Yu ;

Ye, Fei ;

Li, Jiang ;

Nolop, Keith B. ;

Lee, Richard J. ;

Joe, Andrew K. ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (08) :707-714

[8] Resistance to BRAF-targeted therapy in melanoma [J].

Sullivan, Ryan J. ;

Flaherty, Keith T. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1297-1304

[9] Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma [J].

Villanueva, Jessie ;

Infante, Jeffrey R. ;

Krepler, Clemens ;

Reyes-Uribe, Patricia ;

Samanta, Minu ;

Chen, Hsin-Yi ;

Li, Bin ;

Swoboda, Rolf K. ;

Wilson, Melissa ;

Vultur, Adina ;

Fukunaba-Kalabis, Mizuho ;

Wubbenhorst, Bradley ;

Chen, Thomas Y. ;

Liu, Qin ;

Sproesser, Katrin ;

DeMarini, Douglas J. ;

Gilmer, Tona M. ;

Martin, Anne-Marie ;

Marmorstein, Ronen ;

Schultz, David C. ;

Speicher, David W. ;

Karakousis, Giorgos C. ;

Xu, Wei ;

Amaravadi, Ravi K. ;

Xu, Xiaowei ;

Schuchter, Lynn M. ;

Herlyn, Meenhard ;

Nathanson, Katherine L. .

CELL REPORTS, 2013, 4 (06) :1090-1099

[10] Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies [J].

Whittaker, Steven ;

Kirk, Ruth ;

Hayward, Robert ;

Zambon, Alfonso ;

Viros, Amaya ;

Cantarino, Neus ;

Affolter, Annette ;

Nourry, Arnaud ;

Niculescu-Duvaz, Dan ;

Springer, Caroline ;

Marais, Richard .

SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (35)

← 1 2 →